Skip to content
Medical Health Aged Care, Science

New study finds constipation is a significant risk factor for major cardiac events

Monash University 2 mins read

An international study led by Monash University researchers has found a surprising connection between constipation and an increased risk of major adverse cardiac events (MACE), including heart attacks, strokes and heart failure.

The study, led by Professor Francine Marques from the School of Biological Sciences and published in the American Journal of Physiology-Heart and Circulatory Physiology analysed data from over 400,000 participants in the UK Biobank.

“Our study suggests that constipation, a common yet often overlooked health issue, may be a significant contributor to cardiovascular disease,” said Professor Marques.

“Traditional cardiovascular risk factors such as high blood pressure, obesity and smoking have long been recognised as key drivers of heart disease,” she said.

“However, these factors alone do not fully explain the occurrence of major cardiac events.”

“This study explored the potential role of constipation as an additional risk factor, revealing concerning results.”

The research team analysed data from 408,354 individuals, identifying 23,814 cases of constipation.

The findings showed that individuals suffering from constipation were more than twice as likely to suffer from a major cardiac event as those without constipation.

Moreover, the study highlighted a particularly concerning link between constipation and hypertension. 
Hypertensive individuals who also suffered from constipation were found to have a 34 per cent increased risk of subsequent cardiac events compared to those with hypertension alone.

“Our research suggests that constipation may exacerbate the cardiovascular risks associated with high blood pressure, further increasing the likelihood of heart attacks and strokes,” Professor Marques said.

In addition to these epidemiological findings, the study also explored the genetic links between constipation and cardiovascular disease. “Positive genetic correlations were identified between constipation and various forms of MACE, indicating that shared genetic factors may underlie both conditions. This discovery opens new avenues for research into the underlying mechanisms that connect gut health and heart health,” Dr Leticia Camargo Tavares, co-first author of the study, explained.

“The implications of this study are far-reaching,” Professor Marques said.

“With constipation affecting an estimated 14 per cent of the global population, particularly older adults and women, these findings suggest that a significant portion of the population may be at an increased risk of cardiovascular disease due to their bowel health,” she said.

The study authors emphasised the need for further research to explore the causal relationship between constipation and MACE and to identify the specific biological pathways involved. One of these mechanisms may be via a ‘leaky gut’. The team is recruiting participants to answer this question (www.marqueslab.com/gut).

This research challenges the traditional understanding of cardiovascular risk factors and underscores the importance of considering gut health in the prevention and management of heart disease. As the global burden of cardiovascular disease continues to rise, these findings could pave the way for new strategies in personalised medicine, helping to identify individuals at higher risk and potentially reducing the incidence of life-threatening cardiac events.

Media enquiries:
Silvia Dropulich
Marketing, Media & Communications Manager, Monash Science
T: +61 3 9902 4513 M: +61 435 138 743
Email: [email protected]

Hande Cater, Media and Communications Manager, Monash University
M: 0456 428 906
E: [email protected]

 

More from this category

  • Medical Health Aged Care
  • 15/08/2026
  • 07:02
Optimi Health Corp.

Optimi Health Establishes Discretionary Equity Facility

VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.Sales under the ELOC are at the…

  • Science
  • 14/08/2026
  • 08:45
WEHI

From infection to protection: Could mosquitoes help eradicate malaria?

Researchers have discovered a new way to help prevent malaria that could one day transform mosquito bites from a source of deadly infection into…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 14/08/2026
  • 08:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research

MEDIA RELEASE Friday, 14 August 2026 ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research The Australia New Zealand Gynaecological Oncology Group (ANZGOG) has today opened applications for its 2026 Fund for New Research Grant Program, supporting researchers to investigate promising ideas and generate the evidence needed to progress larger studies and future clinical trials. Supported by significant contributions from ANZGOG donors, the 2026 program will fund four priority research areas, with grants ranging from $50,000 to $100,000: Endometrial cancer focused surgical study – one grant of up to $55,000 Leiomyosarcoma focused…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.